What we do not know yet is the efficacy of these vaccines in preventing all infection (symptomatic and asymptomatic). This is of interest in assessing the ability to achieve herd immunity. Only AstraZeneca has published data on asymptomatic infection, and the vaccine is not very effective on that front. READ MORE